Ani Pharmaceuticals (ANIP) EV to EBITDA (2013 - 2026)
Ani Pharmaceuticals' EV to EBITDA was 6.84 in Q2 2026, down 45.0% from 12.42 a year earlier and down 3.8% from the prior quarter.
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) EV to EBITDA (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ani Pharmaceuticals' EV to EBITDA was 3.20 through Jun 30, 2026, down 60.1% year-over-year; for FY2025, it came in at 7.36, down 50.8% from FY2024.
- In earlier years, EV to EBITDA was 14.96 in FY2024 (+73.2%), 8.64 in FY2023 (-67.9%), 26.91 in FY2022 (-58.2%) and 64.37 in FY2021 (+425.0%).
- The Q2 2026 figure marks the lowest quarterly EV to EBITDA in data going back to Q1 2013.
- Compared with a year earlier, EV to EBITDA has declined for four straight quarters, with growth averaging 3.4% over the last eight quarters.
- The best year-over-year quarter for EV to EBITDA over five years was Q4 2021 (growth of 425.0%); the worst was Q4 2023 (a decline of 70.0%).
- Per Business Quant data, ANIP's EV to EBITDA in the three quarters before Q2 2026 was 7.11 (Q1 2026), 7.36 (Q4 2025) and 11.33 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Ani Pharmaceuticals | 1.78 Bn | 565.34 Mn | 165.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.84 |
| Mar 31, 2026 | 7.11 |
| Dec 31, 2025 | 7.36 |
| Sep 30, 2025 | 11.33 |
| Jun 30, 2025 | 12.42 |
| Mar 31, 2025 | 16.26 |
| Dec 31, 2024 | 14.96 |
| Sep 30, 2024 | 15.79 |
| Jun 30, 2024 | 10.26 |
| Mar 31, 2024 | 10.66 |
| Dec 31, 2023 | 8.64 |
| Sep 30, 2023 | 9.84 |
| Jun 30, 2023 | 11.90 |
| Mar 31, 2023 | 12.44 |
| Dec 31, 2022 | 28.79 |
| Dec 31, 2021 | 64.37 |
| Sep 30, 2021 | 14.02 |
| Jun 30, 2021 | 12.03 |
| Mar 31, 2021 | 11.10 |
| Dec 31, 2020 | 12.26 |
API Access
Ani Pharmaceuticals EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ANIP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();